PGI 2 as a regulator of inflammatory diseases

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Dorris, Stacy L ^a   Peebles, R Stokes ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDRO 5 [2 [[ALPHA (3 PYRIDYL)BENZYLIDENE]AMINOOXY]ETHYL] 1 NAPHTHYLOXYACETIC ACID; ARACHIDONIC ACID; BERAPROST; BRADYKININ; CICAPROST; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ILOPROST; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; RANTES; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNIPROST; IMMUNOLOGIC FACTOR;

ADAPTIVE IMMUNITY; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGY; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL TYPE; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; DIABETIC ANGIOPATHY; DIARRHEA; DRUG ERUPTION; DRUG INDICATION; ERYTHEMA; FIBROBLAST; FLUSHING; FOOT PAIN; HEADACHE; HUMAN; HYPOTENSION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; ISCHEMIA; JAW PAIN; LEG PAIN; LIVER INJURY; LUNG EMPHYSEMA; LUNG FIBROSIS; NAUSEA; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; THROMBOCYTE AGGREGATION; VARIABLE NUMBER OF TANDEM REPEAT; DRUG EFFECT; METABOLISM; VASODILATATION;

ADAPTIVE IMMUNITY; EPOPROSTENOL; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; VASODILATION;

EID: 84864936409     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/926968     Document Type: Review

References (47)

1. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B., Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides Nature 1976 261 5561 558 560
2. Camacho M., Rodrguez C., Salazar J., Martnez-Gonzlez J. A., Ribalta J., Escudero J. R., Masana L., Vila L., Retinoic acid induces PGI synthase expression in human endothelial cells Journal of Lipid Research 2008 49 8 1707 1714
3. Gurgul-Convey E., Lenzen S., Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cells The Journal of Biological Chemistry 2010 285 15 11121 11128
4. Jaffar Z., Wan K. S., Roberts K., A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen Journal of Immunology 2002 169 10 5997 6004 (Pubitemid 35291707)
5. Camacho M., Rodrguez C., Guadall A., Alcolea S., Orriols M., Escudero J. R., Martnez-Gonzlez J., Vila L., Hypoxia upregulates PGI-synthase and increases PGI 2 release in human vascular cells exposed to inflammatory stimuli Journal of Lipid Research 2011 52 4 720 731
6. Matsuoka T., Narumiya S., The roles of prostanoids in infection and sickness behaviors Journal of Infection and Chemotherapy 2008 14 4 270 278
7. Yin H., Cheng L., Langenbach R., Ju C., Prostaglandin I2 and E2 mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury Hepatology 2007 45 1 159 169 (Pubitemid 46144375)
8. Egan K. M., Lawson J. A., Fries S., Koller B., Rader D. J., Smyth E. M., FitzGerald G. A., COX-2-derived prostacyclin confers atheroprotection on female mice Science 2004 306 5703 1954 1957 (Pubitemid 39627863)
9. Hui Y., Ricciotti E., Crichton I., Yu Z., Wang D., Stubbe J., Wang M., Puré E., Fitzgerald G. A., Targeted deletions of cyclooxygenase-2 and atherogenesis in mice Circulation 2010 121 24 2654 2660
10. King V. L., Trivedi D. B., Gitlin J. M., Loftin C. D., Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 5 1137 1143 (Pubitemid 43732124)
11. Zou M. H., Ullrich V., Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase The FEBS Letters 1996 382 1-2 101 104 (Pubitemid 26092944)
12. Zou M., Martin C., Ullrich V., Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite Biological Chemistry 1997 378 7 707 713 (Pubitemid 27361864)
13. Wade M. I., Voelkel N. F., Fitzpatrick F. A., Suicide inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells Archives of Biochemistry and Biophysics 1995 321 2 453 458
14. El-Haroun H., Clarke D. L., Deacon K., Bradbury D., Clayton A., Sutcliffe A., Knox A. J., IL-1, BK, and TGF- 1 attenuate PGI 2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA American Journal of Physiology 2008 294 3 L553 L562
15. Mohite A., Chillar A., So S. P., Cervantes V., Ruan K. H., Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression Biochemistry 2011 50 10 1691 1699
16. Soberman R. J., Christmas P., Revisiting prostacyclin: new directions in pulmonary fibrosis and inflammation American Journal of Physiology 2006 291 2 L142 L143
17. Lovgren A. K., Jania L. A., Hartney J. M., Parsons K. K., Audoly L. P., FitzGerald G. A., Tilley S. L., Koller B. H., COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis American Journal of Physiology 2006 291 2 L144 L156
18. Dahlen S. K., Hansson G., Hedqvist P., Bjorck T., Granstrom E., Dahlen B., Allergen challenge of lung tissue from asthmatic elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4 Proceedings of the National Academy of Sciences of the United States of America 1983 80 6 1712 1716 (Pubitemid 13136417)
19. Schulman E. S., Newball H. H., Demers L. M., Fitzpatrick F. A., Adkinson N. F. Jr., Anaphylactic release of thromboxane A2, Prostaglandin D2, and prostacyclin from human lung parenchyma American Review of Respiratory Disease 1981 124 4 402 406 (Pubitemid 11020581)
20. Takahashi Y., Tokuoka S., Masuda T., Hirano Y., Nagao M., Tanaka H., Inagaki N., Narumiya S., Nagai H., Augmentation of allergic inflammation in prostanoid IP receptor deficient mice British Journal of Pharmacology 2002 137 3 315 322
21. Nagao K., Tanaka H., Komai M., Masuda T., Narumiya S., Nagai H., Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice American Journal of Respiratory Cell and Molecular Biology 2003 29 3 314 320 (Pubitemid 37093989)
22. Jaffar Z., Ferrini M. E., Buford M. C., FitzGerald G. A., Roberts K., Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma Journal of Immunology 2007 179 9 6193 6203
23. Wang M., Cooper P. R., Jiang M., Zhao H., Hui Y., Yao Y., Tate J. C., Damera G., Lawson J. A., Jester W. F. Jr., Haczku A., Panettieri R. A. Jr., FitzGerald G. A., Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness Journal of Pharmacology and Experimental Therapeutics 2010 334 1 63 68
24. Idzko M., Hammad H., van Nimwegen M., Kool M., Vos N., Hoogsteden H. C., Lambrecht B. N., Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function Journal of Clinical Investigation 2007 117 2 464 472 (Pubitemid 46203975)
25. Madison L. D., Scarlett J. M., Levasseur P., Zhu X., Newcomb K., Batra A., Bowe D., Marks D. L., Prostacyclin signaling regulates circulating ghrelin during acute inflammation Journal of Endocrinology 2008 196 2 263 273 (Pubitemid 351298511)
26. Vane J., Corin R. E., Prostacyclin: a vascular mediator European Journal of Vascular and Endovascular Surgery 2003 26 6 571 578 (Pubitemid 37461770)
27. Lehmann C., Knig J. P., Dettmann J., Birnbaum J., Kox W. J., Effects of iloprost, a stable prostacyclin analog, on intestinal leukocyte adherence and microvascular blood flow in rat experimental endotoxemia Critical Care Medicine 2001 29 7 1412 1416 (Pubitemid 32641806)
28. Nana-Sinkam S. P., Jong D. L., Sotto-Santiago S., Stearman R. S., Keith R. L., Choudhury Q., Cool C., Parr J., Moore M. D., Bull T. M., Voelkel N. F., Geraci M. W., Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke American Journal of Respiratory and Critical Care Medicine 2007 175 7 676 685 (Pubitemid 46536482)
29. Zhu Y., Liu Y., Zhou W., Xiang R., Jiang L., Huang K., Xiao Y., Guo Z., Gao J., A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice Respiratory Research 2010 11, article 34
30. Zhou W., Dowell D. R., Geraci M. W., Blackwell T. S., Collins R. D., Polosukhin V. V., Lawson W. E., Wu P., Sussan T., Biswal S., Goleniewska K., 'Neal J. O., Newcomb D. C., Toki S., Morrow J. D., Peebles R. S. Jr., PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased Nqo 1 expression American Journal of Physiology 2011 301 4 L615 L622
31. Hashimoto K., Graham B. S., Geraci M. W., FitzGerald G. A., Egan K., Zhou W., Goleniewska K., O'Neal J. F., Morrow J. D., Durbin R. K., Wright P. F., Collins R. D., Suzutani T., Peebles R. S. Jr., Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness Journal of Virology 2004 78 19 10303 10309 (Pubitemid 39258355)
32. Hashimoto K., Ishibashi K., Gebretsadik T., Hartert T. V., Yamamoto A., Nakayama T., Ohashi K., Sakata H., Kawasaki Y., Katayose M., Sakuma H., Suzuki H., Hosoya M., Peebles R. S. Jr., Suzutani T., Functional polymorphism of the promoter region of the prostacyclin synthase gene and severity of RSV infection in hospitalized children Journal of Medical Virology 2008 80 11 2015 2022
33. Pulichino A. M., Rowland S., Wu T., Clark P., Xu D., Mathieu M. C., Riendeau D., Audoly L. P., Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis Journal of Pharmacology and Experimental Therapeutics 2006 319 3 1043 1050
34. Honda T., Segi-Nishida E., Miyachi Y., Narumiya S., Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis Journal of Experimental Medicine 2006 203 2 325 335 (Pubitemid 43290842)
35. Aronoff D. M., Peres C. M., Serezani C. H., Ballinger M. N., Carstens J. K., Coleman N., Moore B. B., Peebles R. S., Faccioli L. H., Peters-Golden M., Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities Journal of Immunology 2007 178 3 1628 1634 (Pubitemid 46154634)
36. Hung C. H., Chu Y. T., Suen J. L., Lee M. S., Chang H. W., Lo Y. C., Jong Y. J., Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues European Respiratory Journal 2009 33 2 405 410
37. Konya V., Sturm E. M., Schratl P., Beubler E., Marsche G., Schuligoi R., Lippe I. T., Peskar B. A., Heinemann A., Endothelium-derived prostaglandin I2 controls the migration of eosinophils Journal of Allergy and Clinical Immunology 2010 125 5 1105 1113
38. Lee I. Y., Ko E. M., Kim S. H., Jeoung D. I., Choe J., Human follicular dendritic cells express prostacyclin synthase: a novel mechanism to control T cell numbers in the germinal center Journal of Immunology 2005 175 3 1658 1664 (Pubitemid 41023069)
39. Mller T., Drk T., Blumenthal B., Herouy Y., Sorichter S., Grimm M., Panther E., Cicko S., Norgauer J., Idzko M., Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells Clinical and Experimental Allergy 2010 40 8 1214 1221
40. Strassheim D., Riddle S. R., Burke D. L., Geraci M. W., Stenmark K. R., Prostacyclin inhibits IFN- -stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner Journal of Immunology 2009 183 11 6981 6988
41. Zhou W., Blackwell T. S., Goleniewska K., O'Neal J. F., FitzGerald G. A., Lucitt M., Breyer R. M., Peebles R. S. Jr., Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells Journal of Leukocyte Biology 2007 81 3 809 817 (Pubitemid 46393559)
42. Zhou W., Hashimoto K., Goleniewska K., O'Neal J. F., Ji S., Blackwell T. S., FitzGerald G. A., Egan K. M., Geraci M. W., Peebles R. S. Jr., Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells Journal of Immunology 2007 178 2 702 710 (Pubitemid 46095142)
43. Kuo C. H., Ko Y. C., Yang S. N., Chu Y. T., Wang W. L., Huang S. K., Chen H. N., Wei W. J., Jong Y. J., Hung C. H., Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation Journal of Molecular Medicine 2011 89 1 29 41
44. Nakajima S., Honda T., Sakata D., Egawa G., Tanizaki H., Otsuka A., Moniaga C. S., Watanabe T., Miyachi Y., Narumiya S., Kabashima K., Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity Journal of Immunology 2010 184 10 5595 5603
45. Kim J., Park C. S., Park C. H., Jeoung D. I., Kim Y. M., Choe J., Beraprost enhances the APC function of B cells by upregulating CD86 expression levels Journal of Immunology 2011 186 7 3866 3873
46. Ivy D. D., Prostacyclin in the intensive care setting Pediatric Critical Care Medicine 2010 11 2 S41 S45
47. Murakami S., Nagaya N., Itoh T., Kataoka M., Iwase T., Horio T., Miyahara Y., Sakai Y., Kangawa K., Kimura H., Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice American Journal of Physiology 2006 290 1 L59 L65